|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7170 EUR | +4.82% |
|
-17.24% | +326.06% |
| 07-16 | Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies | MT |
| 07-16 | Valerio Therapeutics, Abivax Sign R&D Deal for Inflammatory Diseases' Drug Candidates | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1.89% | +3.20% | -0.68% | +20.76% | +10.91% | +59.70% | +165.18% | +352.45% | +1,361.43% | 1,062B | ||
| -0.24% | +0.45% | -0.91% | +14.41% | +24.17% | +50.64% | +52.02% | +48.45% | +106.84% | 619B | ||
| -0.95% | -5.26% | -4.27% | +18.94% | +6.73% | +24.23% | +65.08% | +113.08% | +266.50% | 431B | ||
| +1.81% | +5.06% | +9.43% | +16.71% | +13.19% | +49.14% | +40.27% | +2.53% | +50.28% | 358B | ||
| +1.03% | -0.09% | -0.25% | +11.63% | +15.40% | +35.93% | +40.77% | +49.42% | +56.44% | 293B | ||
| +1.30% | -5.10% | -16.54% | -9.96% | -13.07% | +9.48% | +10.12% | +46.28% | +130.98% | 247B | ||
| -0.73% | +4.44% | +10.48% | +22.27% | +23.69% | +42.22% | +66.41% | +75.91% | +133.13% | 219B | ||
| +3.74% | -0.62% | -6.98% | +3.08% | -6.35% | -1.38% | -44.18% | -4.33% | +91.57% | 200B | ||
| -0.68% | -0.32% | +0.96% | -3.99% | +6.62% | +18.66% | +66.32% | +90.26% | +62.74% | 162B | ||
| +1.51% | +5.18% | +10.46% | -1.24% | +5.22% | +9.49% | -25.19% | -41.87% | -26.07% | 149B | ||
| +0.82% | -1.09% | +13.14% | +13.36% | +18.93% | +43.13% | +6.05% | -5.83% | +1.37% | 131B | ||
| -0.17% | +0.48% | -8.60% | +13.18% | +6.77% | +25.51% | +42.16% | +141.21% | +372.55% | 123B | ||
| +1.05% | +1.32% | -2.30% | +5.30% | +7.26% | +41.50% | +44.73% | +8.09% | -6.70% | 104B | ||
| +1.18% | +0.91% | -0.83% | +1.91% | -9.15% | -7.04% | -20.28% | -13.67% | +4.01% | 103B | ||
| +1.37% | -1.08% | -10.01% | -15.29% | -16.81% | -7.34% | +64.16% | +68.23% | +469.83% | 70.25B | ||
| +1.03% | +3.75% | -1.91% | +33.18% | +34.69% | +96.49% | -4.81% | +5.60% | -48.07% | 55.93B | ||
| +2.12% | +0.49% | +1.69% | +4.33% | +14.58% | +30.97% | +26.69% | +52.91% | +18.02% | 54.68B | ||
| -2.67% | -4.65% | -8.21% | -2.83% | -12.52% | -15.38% | +26.88% | -4.91% | +220.35% | 50.96B | ||
| -0.94% | +1.32% | +0.74% | +9.85% | -1.79% | +4.28% | +14.00% | - | - | 43.92B | ||
| Average | +0.63% | -1.25% | -0.77% | +8.19% | +6.76% | +26.85% | +33.49% | +54.66% | +181.40% | 235.69B | |
| Weighted average by Cap. | +0.61% | -0.69% | -0.46% | +12.54% | +10.09% | +37.40% | +65.55% | +119.06% | +414.12% |
- Stock Market
- Stocks
- ALVIO Stock
- C4X Stock
- Sector Valerio Therapeutics
Select your edition
All financial news and data tailored to specific country editions
















